Device Authority partnership expands route into enterprise IoT security

Tern plc

Device Authority has strengthened its enterprise market positioning through a strategic partnership with Xalient, bringing its KeyScaler platform into a managed cybersecurity model focused on identity-led protection for IoT and OT environments.

Enterprises are continuing to expand connected device estates across operational settings, where unmanaged assets, long device lifecycles and fragmented security processes can increase exposure to cyber risk. As these environments become more complex, demand is shifting towards automated tools that can manage device identity, access and compliance at scale.

The partnership gives Xalient the ability to integrate Device Authority’s KeyScaler technology into its IoT security offering. This is intended to help enterprise customers protect connected devices across complex environments by automating key parts of the device identity lifecycle. These include secure onboarding, credential provisioning, certificate rotation, decommissioning and policy-driven access control.

The collaboration also reflects the growing importance of Zero Trust-aligned security models. Rather than relying on static perimeter defences, enterprises need ways to verify and manage users, devices, workloads and machine identities continuously. KeyScaler is designed for IoT and OT environments, where traditional IT security tools may not be sufficient and where automation can help reduce the burden on internal teams.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines examines factors influencing prescribing decisions

Talking Medicines explains how healthcare professional conversations, clinical considerations and treatment perceptions can provide pharmaceutical companies with deeper insight into prescribing intent beyond traditional campaign metrics.

What HCPs say could reveal prescribing intent

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence prescribing intent.

AI control of machines raises new security questions

AI is gaining the ability to control physical equipment, but establishing that machines are genuine, authorised and secure will be an important part of making this technology safe to deploy.

CAR-T therapy brings new approach to multiple myeloma treatment

CAR-T therapy is being used in multiple myeloma and is being studied earlier in the treatment pathway, with research focused on improving durability, safety and access.

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Search